6.SouthallDP,etal.Frequencyandoutcomeof
disordersofcardiacrhythmandconductionina
populationofnewborninfants.Pediatrics.
1981;68(1):58–66.
7.AndriessenP,etal.Supraventricularescape
rhythmsduringtransientepisodesofbradycardia
inpreterminfants.CardiolYoung.
2001;11(6):626–631.
8.HodgmanJE,HoppenbrouwersT,CabalLA.
Episodesofbradycardiaduringearlyinfancyin
theterm-bornandpreterminfant.AmJDis
Child.1993;147(9):960–964.
9.RijnbeekPR,etal.Newnormallimitsforthe
paediatricelectrocardiogram.EurHeartJ.
2001;22(8):702–711.
10.FriedmanRA,FenrichAL,KerteszNJ.
Congenitalcompleteatrioventricularblock.
PacingClinElectrophysiol.2001;24(11):1681–
1688.
11.MichaelssonM,RiesenfeldT,JonzonA.Natural
historyofcongenitalcompleteatrioventricular
block.PacingClinElectrophysiol.1997;20(8Pt
2):2098–2101.
12.MichaelssonM,EngleMA.Congenitalcomplete
heartblock:aninternationalstudyofthenatural
history.CardiovascClin.1972;4(3):85–101.
13.PinskyWW,etal.Diagnosis,management,and
long-termresultsofpatientswithcongenital
completeatrioventricularblock.Pediatrics.
1982;69(6):728–733.
14.KarpawichPP,etal.Congenitalcomplete
atrioventricularblock:clinicaland
electrophysiologicpredictorsofneedfor
pacemakerinsertion.AmJCardiol.
1981;48(6):1098–1102.
15.LevM,CuadrosH,PaulMH.Interruptionofthe
atrioventricularbundlewithcongenital
atrioventricularblock.Circulation.
1971;43(5):703–710.
16.AokiH,etal.Fetalechocardiographicassessment
ofendocardialfibroelastosisinmaternalantiSSAantibody-associatedcompleteheartblock.
CircJ.2011;75(5):1215–1221.
17.NieldLE,etal.Maternalanti-Roandanti-La
antibody-associatedendocardialfibroelastosis.
Circulation.2002;105(7):843–848.
18.MaenoY,etal.Clinicalcourseoffetalcongenital
atrioventricularblockintheJapanese
population:amulticentreexperience.Heart.
2005;91(8):1075–1079.
19.JaeggiET,etal.Outcomeofchildrenwithfetal,
neonatalorchildhooddiagnosisofisolated
congenitalatrioventricularblock.Asingle
institution'sexperienceof30years.JAmColl
Cardiol.2002;39(1):130–137.
20.IzmirlyPM,etal.Maternalandfetalfactors
associatedwithmortalityandmorbidityina
multi-racial/ethnicregistryofanti-SSA/Roassociatedcardiacneonatallupus.Circulation.
2011;124(18):1927–1935.
21.BuyonJ,etal.Completecongenitalheartblock:
riskofoccurrenceandtherapeuticapproachto
prevention.JRheumatol.1988;15(7):1104–
1108.
22.MolthanME,etal.Congenitalheartblockwith
fatalAdams-Stokesattacksinchildhood.
Pediatrics.1962;30:32–41.
23.ShollerGF,WalshEP.Congenitalcompleteheart
blockinpatientswithoutanatomiccardiac
defects.AmHeartJ.1989;118(6):1193–1198.
24.EpsteinAE,etal.ACC/AHA/HRS2008
Guidelinesfordevice-basedtherapyofcardiac
rhythmabnormalities.HeartRhythm.
2008;5(6):e1–e62.
25.JanousekJ,etal.Permanentcardiacpacingin
children:choosingtheoptimalpacingsite:a
multicenterstudy.Circulation.
2013;127(5):613–623.
26.VestAN,etal.Designandtestingofa
transcutaneousRFrechargingsystemforafetal
micropacemaker.IEEETransBiomedCircuits